Acute lymphangitis is an infection of the lymphatic vessels, most commonly caused by Group A Streptococcus (GAS), presenting with the hallmark finding of linear erythematous streaking extending from a site of skin breach toward regional lymph nodes. [1-3] It represents a complication of cellulitis or wound infection and signals proximal spread of infection through the lymphatic system, warranting prompt antibiotic therapy.
1. History
- Portal of entry: Ask about recent wounds, cuts, abrasions, insect/arthropod bites, puncture injuries, fish spine injuries, or surgical sites [2][4]
- Timing: Onset typically acute (hours to days after skin breach); inquire about incubation period — longer incubation (weeks) suggests atypical organisms such as Sporothrix, Mycobacterium marinum, or Leishmania [5]
- Symptom progression: Red streak extending proximally from wound site, worsening pain, swelling, warmth
- Systemic symptoms: Fever, chills, rigors, malaise, myalgias — suggest bacteremia or progression to sepsis [3]
- Prior treatment: Failed outpatient antibiotics, prior episodes of cellulitis or lymphangitis [6]
- Occupational/exposure history: Gardening (sporotrichosis), aquarium/fish handling (M. marinum), animal contact (tularemia, cat-scratch disease), travel to endemic areas (leishmaniasis) [5]
- Important negatives: Absence of purulent drainage (suggests streptococcal etiology), no crepitus, no pain out of proportion to exam
2. Alarm Features
- Rapid proximal progression of erythematous streaking despite antibiotics
- Systemic toxicity: High fever (>38.5°C), tachycardia, hypotension, altered mental status
- ≥2 SIRS criteria: Suggests moderate-to-severe SSTI requiring IV antibiotics [3][7]
- Crepitus or dusky/necrotic skin: Concern for necrotizing fasciitis — requires emergent surgical consultation [7]
- Pain out of proportion to exam findings
- Immunocompromised host: Diabetes, HIV, chemotherapy, chronic steroid use — higher risk of rapid progression and atypical organisms [3]
- Proximal lymphadenopathy with fluctuance: Suggests abscess formation [8]
- Edema extending to axilla/groin with venous engorgement: Concern for lymphatic obstruction or venous thrombosis [8]
3. Medications
- Relevant contributors: Immunosuppressants (steroids, methotrexate, biologics) increase susceptibility [2]
- First-line outpatient treatment (mild, no SIRS):
- Cephalexin 500 mg PO QID or amoxicillin-clavulanate 875/125 mg PO BID [3]
- Penicillin VK 500 mg PO QID (if pure streptococcal coverage desired)
- Clindamycin 300–450 mg PO TID (penicillin allergy) [3]
- If MRSA suspected (purulent drainage, IVDU, prior MRSA): Add TMP-SMX DS BID or doxycycline 100 mg BID [7]
- IV antibiotics (moderate-severe, ≥2 SIRS criteria, failed oral therapy):
- Cefazolin 1–2 g IV q8h or ceftriaxone 1–2 g IV daily [7]
- Vancomycin (if MRSA concern) + piperacillin-tazobactam (if severe/immunocompromised) [3]
- Penicillin G + clindamycin if concern for streptococcal toxic shock [7]
- Duration: 5 days minimum per IDSA; extend if not improving [3][9]
- Contraindicated: Corticosteroids should be avoided as they can mask underlying malignancy or worsen infection [10]
- Nodular lymphangitis (sporotrichoid pattern): Itraconazole for sporotrichosis; specific therapy guided by culture [5]
4. Diet
- No specific dietary triggers
- Hydration: Encourage adequate oral hydration, especially if febrile
- Diabetic patients: Optimize glycemic control, as hyperglycemia impairs immune function and wound healing
5. Review of Systems
- Constitutional: Fever, chills, rigors, night sweats, fatigue
- Skin: Wound drainage (purulent vs. serous), new skin lesions, nodules along lymphatic channels
- MSK: Joint pain/swelling near affected area (rule out septic arthritis, gout)
- Vascular: Limb swelling, venous engorgement (rule out DVT) [11]
- Respiratory: Pleuritic chest pain (can occur with severe axillary lymphadenitis causing pleural effusion) [8]
6. Collateral History and Family History
- Collateral: Witnesses to mechanism of injury, timeline of symptom onset, prior antibiotic use
- Social context: Homelessness, IVDU (increases MRSA risk and risk of treatment failure) [6][12]
- Occupational exposures: Gardeners, fishermen, veterinarians, laboratory workers — higher risk for atypical organisms [5]
- Family history: Generally not contributory; however, hereditary lymphedema (Milroy disease) predisposes to recurrent lymphangitis
7. Risk Factors
- Skin disruption: Wounds, abrasions, insect bites, tinea pedis, eczema, ulcers [3]
- Lymphedema: Strongly associated with recurrent cellulitis/lymphangitis (OR 6.8); creates a vicious cycle of infection and worsening edema [13]
- Venous insufficiency/chronic edema [3]
- Obesity [3]
- Diabetes mellitus [6][12]
- Immunosuppression: HIV, chemotherapy, chronic corticosteroids [2-3]
- Prior episodes of cellulitis/lymphangitis [3]
- Peripheral vascular disease
- IVDU [7]
8. Differential Diagnosis
- Cellulitis/erysipelas: Diffuse erythema, warmth, swelling without the characteristic linear streaking [3][14]
- Superficial thrombophlebitis: Palpable cord along a vein, erythema follows venous (not lymphatic) distribution [11][15]
- Deep vein thrombosis: Diffuse limb swelling, no streaking, positive Homan sign (unreliable) [11]
- Nonbacterial/reactive lymphangitis: After arthropod bites — mimics bacterial lymphangitis but self-limited, no systemic symptoms, does not respond to or require antibiotics [1][4]
- Nodular (sporotrichoid) lymphangitis: Subcutaneous nodules along lymphatic channels — think Sporothrix, M. marinum, Nocardia, Leishmania, F. tularensis [5][16]
- Necrotizing fasciitis: Pain out of proportion, crepitus, rapid progression, systemic toxicity — surgical emergency [7][11]
- Contact dermatitis: Linear pattern from plant exposure (e.g., poison ivy) can mimic streaking
- Erythema migrans (Lyme disease): Expanding erythematous ring, not linear
- Lymphangitis carcinomatosa: Chronic, non-tender, associated with malignancy (breast, lung)
9. Past Medical History
- Prior cellulitis or lymphangitis episodes (recurrence is common)
- Chronic lymphedema or venous insufficiency [13]
- Diabetes mellitus [12]
- Immunocompromising conditions
- Prior surgeries (especially lymph node dissection, saphenous vein harvest)
- Tinea pedis or other chronic skin conditions serving as portals of entry
10. Physical Exam
- Hallmark finding: Linear erythematous streak extending proximally from a wound or area of cellulitis along the course of lymphatic vessels [1-2]
- Primary lesion: Identify the portal of entry — wound, bite, abrasion, interdigital tinea
- Regional lymphadenopathy: Tender, enlarged nodes draining the affected area [3]
- Surrounding cellulitis: Erythema, warmth, edema, tenderness at the primary site
- Vital signs: Fever, tachycardia — assess for SIRS criteria [7]
- Concerning findings:
- Fluctuance (abscess formation)
- Crepitus (necrotizing infection)
- Bullae, hemorrhagic vesicles, skin necrosis
- Limb edema with venous engorgement (lymphatic/venous obstruction) [8]
- Demarcate borders with skin marker to track progression
11. Lab Studies
- Mild cases: Labs often unnecessary
- Moderate-severe or systemic symptoms:
- CBC with differential (leukocytosis with left shift) [8]
- BMP (assess renal function for antibiotic dosing)
- CRP/ESR (trending response to therapy)
- Blood cultures (positive in ≤5% of cellulitis cases, but obtain if febrile, immunocompromised, or systemically ill) [3]
- Lactate (if sepsis concern)
- Wound culture: If purulent drainage present; not routinely recommended for non-purulent infection [3]
- Nodular lymphangitis: Biopsy with cultures for fungi, mycobacteria, and bacteria [5]
12. Imaging
- Usually unnecessary for straightforward acute lymphangitis
- Ultrasound: If concern for abscess (fluctuance), DVT, or foreign body
- CT with contrast: If concern for deep space abscess, necrotizing fasciitis, or axillary/inguinal abscess [8]
- Duplex ultrasound: To rule out DVT if limb swelling is disproportionate or venous engorgement is present [8]
- Lymphoscintigraphy: Not indicated acutely; used for chronic lymphedema evaluation [13]
13. Special Tests
- ALT-70 Score: Validated clinical prediction rule to differentiate lower extremity cellulitis from pseudocellulitis (score ≥3 favors cellulitis; sensitivity 97.8%) [15]
- LRINEC Score: If necrotizing fasciitis is suspected
- Point-of-care ultrasound (POCUS): Evaluate for abscess (cobblestoning pattern), DVT
- Skin biopsy: Reserved for nodular lymphangitis or atypical/refractory cases — send for histopathology, AFB stain, fungal culture, bacterial culture [5]
- Streptozyme/ASO titers: Occasionally useful retrospectively to confirm streptococcal etiology [8]
14. ECG
- Not routinely indicated for lymphangitis
- Obtain if:
- Sepsis or hemodynamic instability (assess for tachyarrhythmias)
- Pre-existing cardiac disease with new systemic infection
- Concern for endocarditis in IVDU patients
15. Assessment
Acute lymphangitis is a clinical diagnosis based on the characteristic linear erythematous streaking from a site of skin breach extending toward regional lymph nodes, often accompanied by fever and regional lymphadenopathy. It represents proximal spread of infection through lymphatic channels and is most commonly caused by Group A Streptococcus, with S. aureus as a secondary pathogen. [3] The presence of lymphangitis generally indicates a more significant infection than simple cellulitis and should prompt consideration of parenteral antibiotics, particularly in the setting of systemic symptoms. [2]
Severity stratification (per IDSA 2014 guidelines): [3]
- Mild: No SIRS criteria → oral antibiotics
- Moderate: 1–2 SIRS criteria → oral vs. IV antibiotics based on clinical trajectory
- Severe: ≥2 SIRS criteria, hypotension, immunocompromise, rapid progression → IV antibiotics, consider broad-spectrum coverage
Complications: Bacteremia, sepsis, abscess formation, recurrent cellulitis, chronic lymphedema, venous thrombosis (from adjacent lymphatic inflammation). [8][13]
16. Treatment Plan
Initial stabilization
- IV access, fluid resuscitation if septic
- Analgesia (NSAIDs, acetaminophen)
- Limb elevation and immobilization [3]
- Mark borders of erythema/streaking with skin marker and timestamp
Antibiotic therapy (guided by severity and purulence): [3][7]
- Mild (outpatient): Cephalexin 500 mg PO QID or amoxicillin-clavulanate 875/125 mg PO BID × 5–7 days; extend if not improving by day 5
- Moderate (ED observation or admission): Ceftriaxone 1–2 g IV daily or cefazolin 1–2 g IV q8h; transition to oral when improving
- Severe: Vancomycin + piperacillin-tazobactam (or meropenem) if immunocompromised or rapidly progressing [3]
- Nodular/sporotrichoid pattern: Itraconazole 200 mg PO daily for sporotrichosis; clarithromycin or doxycycline for M. marinum; guided by culture results [5]
Wound care: Incision and drainage if abscess present; wound cleansing; tetanus prophylaxis if indicated
Prophylaxis for recurrence: In patients with recurrent episodes (≥3–4/year), prophylactic penicillin V 250 mg PO BID or erythromycin 250 mg PO daily may reduce recurrence; aggressive management of lymphedema and tinea pedis is essential [17-18]
17. Disposition
- Discharge criteria: Mild disease, no SIRS criteria, reliable follow-up, able to tolerate oral antibiotics, no significant comorbidities
- Observation/admission criteria: [6]
- ≥2 SIRS criteria or hemodynamic instability
- Failed outpatient oral antibiotics
- Rapidly progressing streaking despite initial treatment
- Significant comorbidities (uncontrolled diabetes, immunosuppression)
- Concern for necrotizing infection or deep abscess
- Inability to tolerate oral medications
- Erythema >10 cm in maximal length [6]
- ICU admission: Sepsis, toxic shock syndrome, necrotizing fasciitis
- Specialist consultation: Surgery (if abscess, necrotizing fasciitis), infectious disease (atypical organisms, immunocompromised, treatment failure)
18. Follow Up / Return Precautions
- Follow-up: 24–48 hours for reassessment; ensure erythema/streaking is not progressing beyond marked borders
- Expected course: Improvement within 24–48 hours of appropriate antibiotics; complete resolution typically within 7–10 days
- Return immediately for:
- Worsening redness or streaking beyond marked borders
- New fever or worsening systemic symptoms
- Increasing pain, swelling, or development of blisters/skin discoloration
- Inability to tolerate oral medications
- Patient counseling:
- Keep affected limb elevated
- Complete full antibiotic course
- Treat underlying skin conditions (tinea pedis, eczema) to prevent recurrence
- Meticulous wound care and skin hygiene
- Compression therapy and skin care for patients with chronic lymphedema to reduce recurrence [13][17]
References
1. Nonbacterial Causes of Lymphangitis With Streaking. — Cohen BE, Nagler AR, Pomeranz MK. Journal of the American Board of Family Medicine : JABFM. 2016.
2. Red Stripe on Left Forearm After Stung by Fish Gill: A Case Report. — Yu CH, Su YJ. Medicine. 2024.
3. Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America. — Stevens DL, Bisno AL, Chambers HF, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2014.
4. Superficial Lymphangitis After Arthropod Bite: A Distinctive but Underrecognized Entity?. — Marque M, Girard C, Guillot B, Bessis D. Dermatology. 2008.
5. Nodular Lymphangitis: A Distinctive but Often Unrecognized Syndrome. — Kostman JR, DiNubile MJ. Annals of Internal Medicine. 1993.
6. Factors Associated With Decision to Hospitalize Emergency Department Patients With Skin and Soft Tissue Infection. — Talan DA, Salhi BA, Moran GJ, et al. The Western Journal of Emergency Medicine. 2015.
7. Cellulitis: A Review. — Raff AB, Kroshinsky D. The Journal of the American Medical Association. 2016.
8. Severe Streptococcal Axillary Lymphadenitis. — Boyce JM. The New England Journal of Medicine. 1990.
9. Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians. — Lee RA, Centor RM, Humphrey LL, et al. Annals of Internal Medicine. 2021.
10. Lymphadenopathy: Evaluation and Differential Diagnosis. — Falk N, Joseph R, Dieujuste M. American Family Physician. 2025.
11. Clinical Mimics: An Emergency Medicine-Focused Review of Cellulitis Mimics. — Blumberg G, Long B, Koyfman A. The Journal of Emergency Medicine. 2017.
12. Diagnosis and Management of Non-Purulent Cellulitis in the Emergency Department. — Yadav K, Rosenberg H, Eagles D, Suh KN. Cjem. 2019.
13. The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine Expert Opinion Consensus on Lymphedema Diagnosis and Treatment. — Lurie F, Malgor RD, Carman T, et al. Phlebology. 2022.
14. Cellulitis: A Review of Current Practice Guidelines and Differentiation From Pseudocellulitis. — Boettler MA, Kaffenberger BH, Chung CG. American Journal of Clinical Dermatology. 2022.
15. Applying a Clinical Prediction Rule to Distinguish Lower Extremity Cellulitis from Its Mimics. — Bruner LP. American Family Physician. 2021.
16. Sporotrichoid Lymphangitis Due to Group a Streptococcus. — Bishara J, Cohen Y, Gabay B, et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 2001.
17. Antibiotics / Anti-Inflammatories for Reducing Acute Inflammatory Episodes in Lymphoedema of the Limbs. — Badger C, Seers K, Preston N, Mortimer P. The Cochrane Database of Systematic Reviews. 2004.
18. Interventions for the Prevention of Recurrent Erysipelas and Cellulitis. — Dalal A, Eskin-Schwartz M, Mimouni D, et al. The Cochrane Database of Systematic Reviews. 2017.